Treatment · International
JAMA Psychiatry: once-weekly semaglutide in adults with alcohol use disorder
A randomized clinical trial of the GLP-1 agonist semaglutide for alcohol use disorder.
These are short summaries of research and reporting published elsewhere. We link to the original. Mental Hum does not report these stories.
Mental Hum is owned and operated by Dean Shaban
This JAMA Psychiatry randomized trial of once-weekly semaglutide in adults with alcohol use disorder adds to the growing body of evidence that GLP-1 receptor agonists may have effects on craving and consumption beyond their metabolic indications.
The study is small but adds rigor to a question that has been driven largely by anecdote and observational data so far.
Read the full JAMA Psychiatry article for the protocol and outcomes.
Mental Hum is a reading list, not a publisher. The summary above is our own editorial framing; the reporting and analysis live at the source.
More from this beat